About V-Bio Ventures
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life sciences companies. V-Bio Ventures was established in 2015 and works closely with Belgium-based VIB, one of the world’s premier life science institutes. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biopharmaceutical, pharmaceutical, diagnostics and agricultural sectors.
More info: v-bio.ventures
About Seroba Life Sciences
Seroba is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech. The team has deep investment and industry experience enabling Seroba to help entrepreneurs realize their ambitions whilst creating value for investors. The firm has four funds under management and has built a portfolio of investee companies across multiple indications. Seroba partners with entrepreneurs to create and build businesses around extraordinary science.
More info: www.seroba-lifesciences.com
About 3B Future Health Fund
3B Future Health Fund II S.C.A. SICAV-RAIF is a Luxembourg based investment fund with focus on early-stage investment opportunities in Europe and the U.S. in areas of high unmet patient need, mainly oncology and rare disease therapeutics. The Fund is the second investment fund sponsored by Riccardo Braglia, Chairman and General Partner of 3B Future Health Fund I and II, Luxembourg and Executive Chairman of Helsinn Healthcare Group.
More info: 3bfuturehealth.com
About Claris Ventures SGR
Claris Ventures SGR SpA is a biotech-focused venture capital firm based in Turin (Italy), with €85m under management. Its first fund, raised in 2021, is dedicated to high potential biopharma companies arisen from the Italian R&D ecosystem – both local and international. Claris Ventures aims at the highest impact possible on highly unmet patients’ needs, building value around strong science.
More info: www.clarisventures.com
About CDP Venture Capital
CDP Venture Capital is an asset management company (70% owned by CDP Equity and 30% owned by Invitalia) with €1.8b of assets under management. It aims to make venture capital a strategic pillar to Italy’s economic development and innovation, creating the conditions for a
comprehensive and sustainable growth of the venture capital ecosystem. It operates through a series of funds that aim to support start-ups in all their life cycle stages, making both direct and indirect investments.
More info: www.cdpventurecapital.it
About Vertis Venture 3 Tech Transfer
VV3TT is an early-stage closed-end fund managed by VERTIS SGR with the exclusive support of Venture Factory. VV3TT is the first venture capital fund in Italy entirely dedicated to tech transfer from Universities and Public Research bodies launched under the ITATECH platform.
EIF investment in VV3TT is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implement productive investments in the European Union and to ensure increased access to financing.
About Vertis SGR
Vertis is an asset management company specialized in “Innovative Made in Italy” industries. Vertis is the only private equity and venture capital player located in Southern Italy, with headquarters in Naples, and an operative office in Milan. Its senior team has more than 120 years of cross-sectorial experience in finance, industry, research and consulting.
More info: www.vertis.it
About Venture Factory
Venture Factory is the exclusive advisory company of Vertis Venture 3 Technology Transfer fund. It is led by a team of senior professionals with significant background in venture capital, multinational corporations, technology transfer and research. Venture Factory works together with universities, research institutions, corporations and venture capital funds in order to turn great discoveries into successful products, services and companies.
More info: www.venturefactory.tech
About VI Partners
VI Partners is a Swiss-based VC firm advising on investments in early and seed-stage Healtchare and Technology ventures based in and around Switzerland. We invest smart money to support promising innovation-based companies led by outstanding entrepreneurs. Our managing partners have a long-standing track record, working together since almost twenty years. The owners of the funds advised by VI Partners include ten blue-chip Swiss companies, institutional and private investors from Switzerland and abroad, as well as McKinsey Switzerland and ETH Zurich.
More info: www.vipartners.ch
About Indaco Venture Partners SGR
Indaco Venture Partners SGR (“Indaco SGR”) is one of the largest Italian independent venture capital managers with over €350m of capital invested through six funds including Indaco Venture I – launched in 2018 – which raised €134m and Indaco BIO which recently made its first
closing at €95m. Indaco invests in companies that innovate in the field of electronics and robotics, digital, medtech and now biotech/pharma. The SGR’s focus is mainly on the Italian market, but also makes investments in Europe, the United States, Canada, and Israel.
More info: www.indacosgr.com